85 Efter samtidig behandling med carbamazepin, en potent induktor af CYP3A4, var de geometriske middelværdier for Cmax og AUC for aripiprazol henholdsvis 68% og 73% lavere end, hvis aripiprazol (30 mg) blev givet alene.
Following concomitant administration of carbamazepine, a potent inducer of CYP3A4, the geometric means of Cmax and AUC for aripiprazole were 68% and 73% lower, respectively, compared to when aripiprazole (30 mg) was administered alone.